Cerus Corporation
Clinical trials sponsored by Cerus Corporation, explained in plain language.
-
New blood treatment aims to protect kidneys during heart surgery
Disease control CompletedThis study tested a special way to treat donated red blood cells (called the INTERCEPT Blood System) to see if it is as safe and effective as standard blood for patients with anemia who need transfusions during complex heart surgery. About 581 patients took part. The main goal wa…
Phase: PHASE3 • Sponsor: Cerus Corporation • Aim: Disease control
Last updated May 26, 2026 11:08 UTC
-
Platelet storage breakthrough: new light treatment tested in healthy volunteers
Knowledge-focused CompletedThis study looked at whether platelets treated with the INTERCEPT Blood System (using LED light) and stored for 5 days still work well when given back to healthy volunteers. 40 healthy adults donated their own platelets, which were treated and stored, then compared to fresh plate…
Phase: PHASE2 • Sponsor: Cerus Corporation • Aim: Knowledge-focused
Last updated May 26, 2026 11:33 UTC